NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/01/2026
Voltar para busca
Dado oficial do USPTO
2 BIND MOLECULAR INTERACTIONS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
02/01/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 42
Data de depósito
02/06/2021
Data de registro
22/08/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/08/2023
Última transação
02/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
27
Localização do titular
DE
Examinador
OJEYEMI,ASHLEY CHRISTINE
Unidade examinadora
O10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the terms "2 BIND" in red having a strike through above the terms "MOLECULAR INTERACTIONS" in blue. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.".
Titulares e representantes
Titulares
2bind GmbH
Representantes
Elissa A. Tisdahl Weisberg I.P. Law, P.A.
Classificação técnica
Classes Nice
Classe 1Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for scientificresearchlaboratory purposesother than for medical or veterinary purposes; chemicalbiochemical and biological preparations for use in biophysical and biotechnologicalscientificresearchlaboratoryindustrialcommercial process; diagnostic reagentsbuffersbuffer solutionsbuffer-screening stock solutionsbioliquidsligandstherapeutic antibodiesmonoclonal antibodiesantibody reagentsproteinsaptamersantigensbiochemicals for in vitro and in vivo applications for scientificresearchlaboratory purposesall the aforesaid except for medical and veterinary purposes; chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for the developmentmanufacture and research of pharmaceutical preparationmedicinesmedicine productsmedical diagnosticsdiagnostic and analysis productsfoodcosmeticscleaning preparation and disinfectants in the fields of biologybiotechnologybiochemistrychemistrypharmacy and cosmeticsother than for medical or veterinary purposes; chemicalbiochemical and biological preparations for the developmentmanufacture and research of biophysical and biotechnological pharmaceutical preparationmedicinesmedical productsmedical diagnosticsdiagnostic and analysis productsfoodcosmeticscleaning preparationsdisinfectants
Classe 42
Scientific servicesconducting of biophysical interaction analyses by means of microscale thermophoresis technology for determining binding parameters of molecular interactions; scientific laboratory servicesplasmid cloningprotein expression in E. coliprotein purification and fluorescent protein marking; scientific and technological servicesscientific researchanalysistesting in the field of biophysical analytics; research and development services in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industry and cosmetics; medical and pharmaceutical research and development; scientifictechnological and industrial biochemical analysis and research; scientific laboratory services; scientific research laboratory services; analytical scientific laboratory services; conducting of scientific experiments and teststesting of pharmaceuticalscosmeticsfoodstuffmedical productsmedical diagnosticsdiagnosticanalysis products; consultancy in the field of scientificindustrial and technological research and development in the pharmaceuticalmedicinalcosmeticsfood stuffbiotechnology fields; conducting of technical scientific feasibility studies; development of industrial processesdevelopment of testing specifications and procedures in the field of biophysical analytics; development of new products; development of new technology for others in the field of biophysical analytics; services for the development of methods of testing in the fields of pharmaceuticals and vaccinescosmeticsfood stuffmedical productsmedical diagnosticsdiagnostic and analysis products; research and development services and industrialscientific and technological laboratory services in the field of protein and RNA-based medicine developmentantibody developmentprotein analysisaptamer development and the determination of molecular interactions
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
25/09/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
30/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/12/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
30/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/12/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/12/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/11/2023
FIMP
FINAL DISPOSITION PROCESSED
22/11/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/11/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
22/08/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
22/08/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/07/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/06/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
14/06/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2023
PUBO
PUBLISHED FOR OPPOSITION
06/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/05/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/05/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/03/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
22/03/2023
DOCK
ASSIGNED TO EXAMINER
06/03/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/03/2023
GNFR
FINAL REFUSAL E-MAILED
06/03/2023
CNFR
FINAL REFUSAL WRITTEN
06/03/2023
DOCK
ASSIGNED TO EXAMINER
21/02/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/12/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
22/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/08/2022
DOCK
ASSIGNED TO EXAMINER
17/05/2022
RFNT
REFUSAL PROCESSED BY IB
11/04/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/03/2022
RFRR
REFUSAL PROCESSED BY MPU
21/03/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/02/2022
CNRT
NON-FINAL ACTION WRITTEN
17/02/2022
DOCK
ASSIGNED TO EXAMINER
17/02/2022
MAFR
APPLICATION FILING RECEIPT MAILED
18/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/01/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace 2 BIND MOLECULAR INTERACTIONS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.